The Effect of GLP-1 Agonist in Patients With Hypothalamic Obesity: Prospective, Pilot Study

Inclusion Criteria: * Patients diagnosed with a hypothalamic tumor and treated surgically with confirmed hypothalamic damage * 19 years of age or older * Have a body mass index of at least 27 and less than 30 (27≤BMI\<30) and one or more confirmed weight-related medical conditions, or a body mass index of 30 or greater (BMI≥30). * Voluntarily agreed to participate in the study after receiving a full explanation of the study. Exclusion Criteria: * Unable to fully understand the instructions for participation in the study or unable to give voluntary consent. * Presence or history of a medical condition or disease that, in the opinion of the investigator, would make it difficult for the patient to participate fully for the duration of the study or to interpret the results of the study * Taking medications that may affect weight, except for hormone replacement therapy, in the last 6 months * non-primary tumor patient * Diagnosis of severe renal dysfunction, liver dysfunction, or thyroid disease among other underlying conditions